Industry Insights

  1. RNA interference and the mechanism of messenger RNA degradation 9/27/2000

    Post-transcriptional gene silencing or RNA interference has captured the imagination of scientists working on organisms ranging from Drosophila to Neurospora to petunias...

  2. The Cancer Drug Shortage: When Quality Fails 7/7/2023

    Our industry is failing cancer patients with the current cancer drug shortage. Why is this happening and what can we do about it? This expert provides her insights from the perspective of a quality control professional.

  3. Dispelling 4 Common Myths Of Data Quality Governance 3/9/2023

    Achieving robust data quality governance doesn't need to be an unwieldy prospect. Here, we dispel the four common myths of data quality governance and share the three phases of a good data quality governance program.

  4. How Eli Lilly's Making Peptides Faster And More Reliably 7/17/2024

    Three company leaders answer questions about the IE2b project, which is receiving an ISPE 2024 Facility of the Year Award for its ingenuity of complexity.

  5. Commercial Vs. Technical Priorities: The PM High-Wire Act 2/21/2024

    PMs must be technically adept enough to understand a project, but their main role is to ensure it delivers in terms of scope and budget.

  6. Digital Twins And Mechanistic Models For Optimized Bioprocessing 3/24/2025

    Integrating AI and having a robust IT infrastructure is crucial for modernizing your processes. Discover how digital twins and mechanistic modeling are revolutionizing biomanufacturing, enhancing efficiency, and reducing costs.

  7. Achieving EU GMP Annex 1 Compliance For Contamination Control 3/4/2025

    Gain insight into three areas that have been key in ensuring a robust contamination control strategy to help ensure compliance with the updated Annex 1 regulation: planning, people, and products.

  8. The Largest LOE Event In US Pharma History

    Ahead of the first biosimilar Humira product set to launch in 365 days, this article provides a comprehensive run-down of where biosimilar sponsors stand and the key issues ahead of market formation.

  9. Designing For Full cGMP Production At Pilot Scale 6/17/2024

    Explore how early adoption of fully compendial, cGMP raw materials can provide a return on investment by reducing steps in your process and potential yield losses and avoiding lost production time. 

  10. A Quality Agreement Primer: What To Include & Who To Assign It To 10/16/2020

    Part one of this three-part series on quality agreements discussed identifying key risks in partnering with contract companies and working with vendors. Part two explored the regulations and enforcement activities associated with quality agreements. In this final part, we examine what to include in quality agreements and who should be responsible for the assigned tasks.